BAX vs IRMD
BAX: A diversified healthcare company producing sterile IV solutions, infusion systems, parenteral nutrition, inhaled anesthetics, surgical sealants, smart beds, and patient monitoring systems for hospitals and home care globally. IRMD: A specialist medical device company providing the only known MRI-compatible non-magnetic IV infusion pumps and advanced patient vital signs monitoring systems for the magnetic resonance imaging environment.
Side-by-side fundamentals
| Metric | BAX | IRMD | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $21.74 | $94.08 | |
| Market cap as of 2026-07-23 | $11.5B | $1.2B | |
| P/E as of 2026-07-23 | n/a | 51.42 | |
| PEG as of 2026-07-23 | -0.15 | 2.77 | BAX lower |
| Net margin as of 2026-07-23 | -9.7% | +27.4% | IRMD higher |
| Gross margin as of 2026-07-23 | +30.7% | +76.8% | IRMD higher |
| Operating margin as of 2026-07-23 | -2.5% | +32.4% | IRMD higher |
| ROE as of 2026-07-23 | -16.4% | +24.5% | IRMD higher |
| ROA as of 2026-07-23 | -5.4% | +21.3% | IRMD higher |
| Debt / equity as of 2026-07-23 | 1.57 | 0.00 | IRMD lower |
| Revenue growth (YoY) as of 2026-07-23 | -4.8% | +14.8% | IRMD higher |
| Revenue CAGR (3y) SEC XBRL | +3.8% | +16.3% | IRMD higher |
| Dividend yield as of 2026-07-23 | +0.2% | +0.8% | IRMD higher |
| Dividend streak (yrs) SEC XBRL | 1 | 1 | Tie |
| Beta as of 2026-07-23 | 0.61 | 0.92 | |
| 1-year return as of 2026-07-22 close | -18.9% | +69.0% | IRMD higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.